- Report
- September 2026
- 196 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- April 2026
- 200 Pages
Global
From €2729EUR$2,990USD£2,339GBP
- Report
- September 2026
- 194 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- September 2026
- 182 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- September 2026
- 195 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- September 2026
- 379 Pages
Global
From €5339EUR$5,850USD£4,575GBP
- Report
- September 2026
- 224 Pages
Global
From €5339EUR$5,850USD£4,575GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- January 2026
- 199 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- January 2026
- 181 Pages
Global
From €4107EUR$4,500USD£3,519GBP
- Report
- April 2026
- 147 Pages
Global
From €2737EUR$2,999USD£2,346GBP
€3650EUR$3,999USD£3,128GBP
- Report
- July 2026
- 160 Pages
Global
From €4335EUR$4,750USD£3,715GBP
- Report
- April 2026
- 191 Pages
Global
From €4427EUR$4,850USD£3,793GBP
- Report
- August 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- July 2026
- 160 Pages
Global
From €3030EUR$3,320USD£2,597GBP
€3788EUR$4,150USD£3,246GBP
- Report
- October 2025
- 160 Pages
Global
From €2884EUR$3,160USD£2,471GBP
€3605EUR$3,950USD£3,089GBP
- Report
- April 2026
- 200 Pages
United States
From €2729EUR$2,990USD£2,339GBP

Desflurane is a volatile anesthetic drug used in the induction and maintenance of general anesthesia. It is a halogenated ether, and is one of the most commonly used inhalational anesthetics in modern clinical practice. Desflurane is a colorless liquid at room temperature, with a boiling point of 23.5°C. It has a low blood/gas partition coefficient, meaning it is rapidly eliminated from the body, and has a low solubility in blood, making it suitable for use in rapid-sequence induction. Desflurane is also known for its low incidence of postoperative nausea and vomiting.
Desflurane is available in a variety of formulations, including premixed solutions, vaporizers, and inhalers. It is manufactured by several companies, including Baxter, Hospira, and AbbVie. Other companies involved in the production and distribution of desflurane include B. Braun, Fresenius Kabi, and Merck. Show Less Read more